ARCHIVES

ODAC Recommends Ethyol, DaunoXome For FDA Approval

This article is from The Cancer Letter archive.

Vol. 21 No. 24 | June 16, 1995

Download PDF Visit The Full Archive

Related Articles

Research Integrity: Collins’ Student Falsified Data, ORI Finds

August 22, 1997

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

NCI Program: Hughes Institute Official To Head Cancer Biology

July 23, 1999

Adamson Is Named Acting Deputy; Broder Begins Search For Roper Replacement

May 25, 1990

In Brief: McDonnell Foundation Selects Five For $400,000 Fellowships; Alberts, Verma Picked For Awards

January 4, 1991

Rauscher Tabs Oak Ridge Immunologists To Head Basic Research At Frederick

August 30, 1974